-
Coronavirus Disease 2019 (COVID-19) Update: Foreign Inspections
FDA
March 11, 2020
The FDA updated on the status of U.S. Food and Drug Administration inspections outside of the U.S. in response to the COVID-19 outbreak.
-
Oral Vaccines: A New Drug Development Area that Must be Paid Attention to under the COVID-19 Epidemic
PharmaSources/Miling
March 10, 2020
The “oral vaccines” that can produce mucosal immunity must be an effective way to control the novel coronavirus and also hepatitis C, hepatitis B, human papilloma virus, and influenza virus, etc.
-
DCAT Week 2020 Cancelled Amid COVID-19 Outbreak
americanpharmaceuticalreview
March 10, 2020
The DCAT Board of Directors has released the following announcement regarding their planned event in March ...
-
Development initiated for a plasma-derived COVID-19 therapy
europeanpharmaceuticalreview
March 10, 2020
An anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) is being developed to treat infected, high-risk individuals with COVID-19.
-
Coronavirus Update: FDA and FTC Warn Seven Companies Selling Fraudulent Products that Claim to Treat or Prevent COVID-19
PRNewswire
March 10, 2020
The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling fraudulent COVID-19 products. These products are unapproved drugs that pose significant risks to patient health and vi
-
Individual response to COVID-19 'as important' as government action
worldpharmanews
March 09, 2020
How individuals respond to government advice on preventing the spread of COVID-19 will be at least as important, if not more important, than government action ...
-
Mologic Receives Financial Award to Develop Rapid Diagnostic Test for COVID-19
americanpharmaceuticalreview
March 09, 2020
Mologic has been awarded circa £1 million by the Wellcome Trust and the Department for International Development (DFID) ), as part of the UK government’s £46 million international coronavirus (COVID-19) prevention ...
-
EpiVax partners with UGA researcher on Covid-19 vaccine
pharmaceutical-technology
March 09, 2020
EpiVax has partnered with University of Georgia (UGA) researcher Ted Ross for the development of a vaccine against Covid-19 caused by the coronavirus.
-
German researchers identify potential drug for Covid-19
pharmaceutical-technology
March 09, 2020
Scientists at the German Primate Center – Leibniz Institute for Primate Research have found that an existing drug may help treat Covid-19.
-
Vir Biotechnology and Alnylam partner in fight against Covid-19
pharmaceutical-technology
March 09, 2020
Clinical-stage immunology firm Vir Biotechnology and biopharmaceutical company Alnylam Pharmaceuticals have extended their existing partnership to advance RNAi therapeutics to treat coronavirus infections, including Covid-19.